Doheny Asset Management /Ca Vertex Pharmaceuticals Inc Transaction History

Doheny Asset Management /Ca

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $284,652 - $331,801	-1,375 Closed	0 $0
Q4 2020 Feb 26, 2021	BUY	$207.01 - $276.09 $284,638 - $379,623	1,375 New	1,375 $325,000
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $378,603 - $437,851	-2,300 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $376,579 - $447,810	2,300 New	2,300 $423,000
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $18,988 - $24,026	125 Added 3.14%	4,100 $679,000
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $570,282 - $655,316	-3,400 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$145.72 - $169.96 $495,448 - $577,864	3,400 New	3,400 $578,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

Stay updated on Doheny Asset Management /Ca with notifications on news.